CKB Promotes Mitochondrial ATP Production by Suppressing Permeability Transition Pore
Advanced Science · 2024-08 · 11 (31)
DOI: 10.1002/advs.202403093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.06.2024. Verfasst von Le He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, Chin…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Mitochondrial Permeability Transition Pore, Mitochondria. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Creatine kinases are essential for maintaining cellular energy balance by facilitating the reversible transfer of a phosphoryl group from ATP to creatine, however, their role in mitochondrial ATP production remains unknown. This study shows creatine kinases, including CKMT1A, CKMT1B, and CKB, are highly expressed in cells relying on the mitochondrial F1F0 ATP synthase for survival. Interestingly, silencing CKB, but not CKMT1A or CKMT1B, leads to a loss of sensitivity to the inhibition of F1F0 ATP synthase in these cells. Mechanistically, CKB promotes mitochondrial ATP but reduces glycolytic ATP production by suppressing mitochondrial calcium (mCa 2+ ) levels, thereby preventing the activation of mitochondrial permeability transition pore (mPTP) and ensuring efficient mitochondrial ATP generation. Further, CKB achieves this regulation by suppressing mCa 2+ levels through the inhibition of AKT activity. Notably, the CKB‐AKT signaling axis boosts mitochondrial ATP production in cancer cells growing in a mouse tumor model. Moreover, this study also uncovers a decline in CKB expression in peripheral blood mononuclear cells with aging, accompanied by an increase in AKT signaling in these cells. These findings thus shed light on a novel signaling pathway involving CKB that directly regulates mitochondrial ATP production, potentially playing a role in both pathological and physiological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.
- State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200123, China.
- Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji Univers…
ORCID-Profile: Hui Li, Yufeng Shi
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, L., Lin, J., Lu, S., Li, H., Chen, J., Wu, X., Yan, Q., Liu, H., Li, H., & Shi, Y. (2024). CKB Promotes Mitochondrial ATP Production by Suppressing Permeability Transition Pore. Advanced Science, 11(31). https://doi.org/10.1002/advs.202403093
Vancouver
He L, Lin J, Lu S, Li H, Chen J, Wu X, et al. CKB Promotes Mitochondrial ATP Production by Suppressing Permeability Transition Pore. Advanced Science. 2024;11(31). doi:10.1002/advs.202403093
BibTeX
@article{He2024,
author = {He, Le and Lin, Jianghua and Lu, Shaojuan and Li, Hao and Chen, Jie and Wu, Xinyi and Yan, Qixin and Liu, Hailiang and Li, Hui and Shi, Yufeng},
title = {CKB Promotes Mitochondrial ATP Production by Suppressing Permeability Transition Pore},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {31},
doi = {10.1002/advs.202403093}
}
EUVIMED